Asymptomatic Bacterial Vaginosis Is Associated With Depletion of Mature Superficial Cells Shed From the Vaginal Epithelium

D Elizabeth O'Hanlon, Pawel Gajer, Rebecca M Brotman, Jacques Ravel, D Elizabeth O'Hanlon, Pawel Gajer, Rebecca M Brotman, Jacques Ravel

Abstract

Previous studies have described bacterial vaginosis (BV) as associated with increased cell-shedding from the cervicovaginal epithelium. Cell-shedding in excess of cell-proliferation is thought to decrease epithelial barrier function and increase susceptibility to infection. This study evaluated the number of shed cells in mid-vaginal smears from women with a diagnosis of symptomatic BV (sBV, n = 17), asymptomatic BV (aBV, n = 71), or no BV (n = 104) by Amsel criteria. The sBV smears contained significantly more shed cells (median 158/100X field) than no BV smears (median 91/100X field), p = 7.2e-9. However, we observed that aBV smears contained significantly fewer shed cells (median 35/100X field) than no BV smears, p = 22.0e-16. The sizes of cell-aggregates (cells shed in sometimes multilayered sections with intact cell-cell attachments) followed the same pattern. Cell-aggregates in sBV smears were significantly larger (median ~220,000 μm2) than those in no BV smears (median ~50,000 μm2), p = 1.8e-6, but cell-aggregates in aBV smears were significantly smaller (median ~7,000 μm2) than those in no BV smears, p = 0.0028. We also compared the superficial cell index (SCI), a measure of cervicovaginal epithelial cell maturity, in no BV and aBV smears with relatively low numbers of shed cells (≤50/100X field). The SCI of no BV smears was significantly higher (median 0.86) than that of aBV smears (median 0.35), p = 4.3e-98, suggesting a depletion of mature cells with exposure and shedding of underlying immature cells in aBV with low number of shed cells. These results indicate that aBV may contribute disproportionately to the increased susceptibility to reproductive tract infections associated with BV. Our findings remained true when considering only those smears in which the microbiota comprised a diverse set of strict and facultative anaerobic bacteria [Community State Type IV (n = 162)], thus excluding those dominated by Lactobacillus spp. This is consistent with our developing hypothesis that high-shedding sBV and low-shedding aBV could be temporally separated phases of the same condition, rather than two separate forms of BV. These findings might inform future work on clinical management of symptomatic and asymptomatic bacterial vaginosis.

Keywords: BV; gynecology; vaginal microbiome; vaginal microbiota; women's health.

Copyright © 2020 O'Hanlon, Gajer, Brotman and Ravel.

Figures

Figure 1
Figure 1
Bright-field micrographs (100X total magnification). (A) No Amsel-BV sample with cell count >100/100X field, showing predominantly superficial cells shed as singletons. (B) Symptomatic Amsel-BV sample with cell count >100/100X field, showing predominantly superficial cells shed in large aggregates. (C) No Amsel-BV sample with cell count <50/100X field, showing predominantly superficial cells. (D) Asymptomatic Amsel-BV sample with cell count <50/100X, showing superficial cells (example marked s) shed in combination with intermediate (example marked i) and parabasal (example marked p) cells. Scale bars represent 100 μm.
Figure 2
Figure 2
(A) Box-percentile plot of log10 mean epithelial cell counts in different Amsel diagnostic groups. Dash line indicates 50 mean epithelial cells. (B) Box-percentile plot of log10 mean cell-aggregate sizes in different diagnostic groups. The median, 25 and 75th percentiles are marked with line segments across each box. Numbers at the top axis indicate the number of samples in each group. Ticks within percentile-boxes show individual sample values.
Figure 3
Figure 3
(A) Bright-field micrograph (100X total magnification) showing sample with single cells and small cell-aggregates. (B) Photograph without magnification showing samples with cell-aggregates large enough to see with the naked eye.
Figure 4
Figure 4
Box-percentile plot of superficial cell index in no Amsel-BV and asymptomatic Amsel-BV samples with a mean epithelial cell counts of

Figure 5

(A) Box-percentile plot of log…

Figure 5

(A) Box-percentile plot of log 10 mean epithelial cell counts in different diagnostic…
Figure 5
(A) Box-percentile plot of log10 mean epithelial cell counts in different diagnostic groups for only CST IV samples. Dash line indicates 50 mean epithelial cells. (B) Box-percentile plot of log10 mean cell-aggregate sizes in different diagnostic groups for only CST IV samples. The median, 25 and 75th percentiles are marked with line segments across each box. Numbers at the top axis indicate the number of samples in each group. Ticks within percentile-boxes show individual sample values.

Figure 6

Box-percentile plot of superficial cell…

Figure 6

Box-percentile plot of superficial cell index in no Amsel-BV and asymptomatic Amsel-BV samples…

Figure 6
Box-percentile plot of superficial cell index in no Amsel-BV and asymptomatic Amsel-BV samples for only CST IV samples with a mean epithelial cell counts of

Figure 7

Conceptual model hypothesizing that sBV…

Figure 7

Conceptual model hypothesizing that sBV may be rapidly followed by aBV. Under this…

Figure 7
Conceptual model hypothesizing that sBV may be rapidly followed by aBV. Under this hypothesis, the increased cell-shedding events associated with sBV exhaust the superficial and intermediate epithelial cell layers resulting in reduced cell-shedding, and exposure and loss of immature epithelial cells (low SCI) associated with aBV. This progression is hypothesized to be associated with increased risk of infections.
All figures (7)
Similar articles
Cited by
References
    1. Amegashie C. P., Gilbert N. M., Peipert J. F., Allsworth J. E., Lewis W. G., Lewis A. L. (2017). Relationship between nugent score and vaginal epithelial exfoliation. PLoS ONE 12:e0177797. 10.1371/journal.pone.0177797 - DOI - PMC - PubMed
    1. Amsel R., Totten P. A., Spiegel C. A., Chen K. C., Eschenbach D., Holmes K. K. (1983). Non-specific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74, 14–22. 10.1016/0002-9343(83)91112-9 - DOI - PubMed
    1. Anahtar M. N., Byrne E. H., Doherty K. E., Bowman B. A., Yamamoto H. S., Soumillon M., et al. . (2015). Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity 42, 965–976. 10.1016/j.immuni.2015.04.019 - DOI - PMC - PubMed
    1. Anderson D. J., Marathe J., Pudney J. (2014). The structure of the human vaginal stratum corneum and its role in immune defense. Am. J. Reprod. Immunol. 71, 618–623. 10.1111/aji.12230 - DOI - PMC - PubMed
    1. Atashili J., Poole C., Ndumbe P. M., Adimora A. A., Smith J. S. (2008). Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22, 1493–1501. 10.1097/QAD.0b013e3283021a37 - DOI - PMC - PubMed
Show all 44 references
Publication types
Related information
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 5
Figure 5
(A) Box-percentile plot of log10 mean epithelial cell counts in different diagnostic groups for only CST IV samples. Dash line indicates 50 mean epithelial cells. (B) Box-percentile plot of log10 mean cell-aggregate sizes in different diagnostic groups for only CST IV samples. The median, 25 and 75th percentiles are marked with line segments across each box. Numbers at the top axis indicate the number of samples in each group. Ticks within percentile-boxes show individual sample values.
Figure 6
Figure 6
Box-percentile plot of superficial cell index in no Amsel-BV and asymptomatic Amsel-BV samples for only CST IV samples with a mean epithelial cell counts of

Figure 7

Conceptual model hypothesizing that sBV…

Figure 7

Conceptual model hypothesizing that sBV may be rapidly followed by aBV. Under this…

Figure 7
Conceptual model hypothesizing that sBV may be rapidly followed by aBV. Under this hypothesis, the increased cell-shedding events associated with sBV exhaust the superficial and intermediate epithelial cell layers resulting in reduced cell-shedding, and exposure and loss of immature epithelial cells (low SCI) associated with aBV. This progression is hypothesized to be associated with increased risk of infections.
All figures (7)
Figure 7
Figure 7
Conceptual model hypothesizing that sBV may be rapidly followed by aBV. Under this hypothesis, the increased cell-shedding events associated with sBV exhaust the superficial and intermediate epithelial cell layers resulting in reduced cell-shedding, and exposure and loss of immature epithelial cells (low SCI) associated with aBV. This progression is hypothesized to be associated with increased risk of infections.

References

    1. Amegashie C. P., Gilbert N. M., Peipert J. F., Allsworth J. E., Lewis W. G., Lewis A. L. (2017). Relationship between nugent score and vaginal epithelial exfoliation. PLoS ONE 12:e0177797. 10.1371/journal.pone.0177797
    1. Amsel R., Totten P. A., Spiegel C. A., Chen K. C., Eschenbach D., Holmes K. K. (1983). Non-specific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74, 14–22. 10.1016/0002-9343(83)91112-9
    1. Anahtar M. N., Byrne E. H., Doherty K. E., Bowman B. A., Yamamoto H. S., Soumillon M., et al. . (2015). Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity 42, 965–976. 10.1016/j.immuni.2015.04.019
    1. Anderson D. J., Marathe J., Pudney J. (2014). The structure of the human vaginal stratum corneum and its role in immune defense. Am. J. Reprod. Immunol. 71, 618–623. 10.1111/aji.12230
    1. Atashili J., Poole C., Ndumbe P. M., Adimora A. A., Smith J. S. (2008). Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22, 1493–1501. 10.1097/QAD.0b013e3283021a37
    1. Brotman R. M., Bradford L. L., Conrad M., Gajer P., Ault K., Peralta L., et al. . (2012). Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women. Sex Transm. Dis. 39, 807–812. 10.1097/OLQ.0b013e3182631c79
    1. Brotman R. M., Shardell M. D., Gajer P., Tracy J. K., Zenilman J. M., Ravel J., et al. . (2014). Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J. Infect. Dis. 210, 1723–1733. 10.1093/infdis/jiu330
    1. Cherpes T. L., Meyn L. A., Krohn M. A., Lurie J. G., Hillier S. L. (2003). Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin. Infect. Dis. 37, 319–325. 10.1086/375819
    1. Cone R. A., Hoen T., Wong X., Abusuwwa R., Anderson D. J., Moench T. R. (2006). Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect. Dis. 6:90. 10.1186/1471-2334-6-90
    1. Edwards V. L., Smith S. B., Mccomb E. J., Tamarelle J., Ma B., Humphrys M. S., et al. . (2019). The cervicovaginal microbiota-host interaction modulates Chlamydia trachomatis infection. MBio 10, e01548–e01519. 10.1128/mBio.01548-19
    1. Eschenbach D. A., Hillier S., Critchlow C., Stevens C., Derouen T., Holmes K. K. (1988). Diagnosis and clinical manifestations of bacterial vaginosis. Am. J. Obstet. Gynecol. 158, 819–828. 10.1016/0002-9378(88)90078-6
    1. Fadrosh D. W., Ma B., Gajer P., Sengamalay N., Ott S., Brotman R. M., et al. . (2014). An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome 2:6. 10.1186/2049-2618-2-6
    1. Fleury F. J. (1983). The clinical signs and symptoms of Gardnerella-associated vaginosis. Scand J. Infect. Dis. Suppl. 40, 71–72.
    1. Fowler R. S. (2012). Quantification of normal vaginal constituents using a new wet preparation technique. J. Low Genit. Tract. Dis. 16, 437–441. 10.1097/LGT.0b013e31825a8b08
    1. Gajer P., Brotman R. M., Bai G., Sakamoto J., Schütte U. M., Zhong X., et al. . (2012). Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4:132ra152. 10.1126/scitranslmed.3003605
    1. Gosmann C., Anahtar M. N., Handley S. A., Farcasanu M., Abu-Ali G., Bowman B. A., et al. . (2017). Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity 46, 29–37. 10.1016/j.immuni.2016.12.013
    1. Hardy L., Jespers V., Abdellati S., De Baetselier I., Mwambarangwe L., Musengamana V., et al. . (2016). A fruitful alliance: the synergy between Atopobium vaginae and Gardnerella vaginalis in bacterial vaginosis-associated biofilm. Sex Transm. Dis. 92, 487–491. 10.1136/sextrans-2015-052475
    1. Hickey D. K., Patel M. V., Fahey J. V., Wira C. R. (2011). Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J. Reprod. Immunol. 88, 185–194. 10.1016/j.jri.2011.01.005
    1. Hillier S. L., Moench T., Shattock R., Black R., Reichelderfer P., Veronese F. (2005). In vitro and in vivo: the story of nonoxynol 9. J. Acquir. Immune Defic. Syndr. 39, 1–8. 10.1097/01.qai.0000159671.25950.74
    1. Hoffman I. F., Taha T. E., Padian N. S., Kelly C. W., Welch J. D., Martinson F. E., et al. . (2004). Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa. AIDS 18, 2191–2195. 10.1097/00002030-200411050-00012
    1. Jespers V., Kyongo J., Joseph S., Hardy L., Cools P., Crucitti T., et al. . (2017). A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa. Sci. Rep. 7:11974. 10.1038/s41598-017-12198-6
    1. Klebanoff M. A., Schwebke J. R., Zhang J., Nansel T. R., Yu K. F., Andrews W. W. (2004). Vulvovaginal symptoms in women with bacterial vaginosis. Obstet. Gynecol. 104, 267–272. 10.1097/01.AOG.0000134783.98382.b0
    1. Marchesi J. R., Ravel J. (2015). The vocabulary of microbiome research: a proposal. Microbiome 3:31. 10.1186/s40168-015-0094-5
    1. Mckinnon L. R., Achilles S. L., Bradshaw C. S., Burgener A., Crucitti T., Fredricks D. N., et al. . (2019). The evolving facets of bacterial vaginosis: implications for HIV transmission. AIDS Res. Hum. Retroviruses 35, 219–228. 10.1089/aid.2018.0304
    1. Mirmonsef P., Gilbert D., Zariffard M. R., Hamaker B. R., Kaur A., Landay A. L., et al. . (2011). The effects of commensal bacteria on innate immune responses in the female genital tract. Am. J. Reprod. Immunol. 65, 190–195. 10.1111/j.1600-0897.2010.00943.x
    1. Mitra A., Macintyre D. A., Marchesi J. R., Lee Y. S., Bennett P. R., Kyrgiou M. (2016). The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome 4:58. 10.1186/s40168-016-0203-0
    1. Niruthisard S., Roddy R. E., Chutivongse S. (1991). The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm. Dis. 18, 176–179. 10.1097/00007435-199107000-00010
    1. Nugent R. P., Krohn M. A., Hillier S. L. (1991). Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 29, 297–301. 10.1128/JCM.29.2.297-301.1991
    1. Nunn K. L., Wang Y. Y., Harit D., Humphrys M. S., Ma B., Cone R., et al. . (2015). Enhanced trapping of HIV-1 by human cervicovaginal mucus is associated with Lactobacillus crispatus-dominant microbiota. MBio 6, e01084–e01015. 10.1128/mBio.01084-15
    1. Ravel J. (2018). “Progress toward an in-depth understanding of the vaginal microbiome,” Keystone Symposium, Role of the Genital Tract Microbiome in Sexual and Reproductive Health Southern Sun Cape Sun. Cape Town, Western Cape South Africa.
    1. Ravel J., Brotman R. M., Gajer P., Ma B., Nandy M., Fadrosh D. W., et al. . (2013). Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome 1:29. 10.1186/2049-2618-1-29
    1. Roberts J. N., Buck C. B., Thompson C. D., Kines R., Bernardo M., Choyke P. L., et al. . (2007). Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 13, 857–861. 10.1038/nm1598
    1. Smith-Mccune K., Chen J. C., Greenblatt R. M., Shanmugasundaram U., Shacklett B. L., Hilton J. F., et al. . (2015). Unexpected inflammatory effects of intravaginal gels (universal placebo gel and nonoxynol-9) on the upper female reproductive tract: a randomized crossover study. PLoS ONE 10:e0129769. 10.1371/journal.pone.0129769
    1. Stupnicki R., Teter J. (1970). A dynamic approach to the evaluation of oestrogenic effects on the vaginal epithelium in women. J. Reprod. Fertil. 22, 563–567. 10.1530/jrf.0.0220563
    1. Tachedjian G., Aldunate M., Bradshaw C. S., Cone R. A. (2017). The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res. Microbiol. 168, 782–792. 10.1016/j.resmic.2017.04.001
    1. Taha T. E., Hoover D. R., Dallabetta G. A., Kumwenda N. I., Mtimavalye L. A., Yang L. P., et al. . (1998). Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12, 1699–1706. 10.1097/00002030-199813000-00019
    1. Thurman A. R., Kimble T., Herold B., Mesquita P. M., Fichorova R. N., Dawood H. Y., et al. . (2015). Bacterial vaginosis and subclinical markers of genital tract inflammation and mucosal immunity. AIDS Res. Hum. Retroviruses 31, 1139–1152. 10.1089/aid.2015.0006
    1. Vincent K. L., Stanberry L. R., Moench T. R., Breitkopf C. R., Loza M. L., Wei J., et al. . (2011). Optical coherence tomography compared with colposcopy for assessment of vaginal epithelial damage: a randomized controlled trial. Obstet. Gynecol. 118, 1354–1361. 10.1097/AOG.0b013e318238f563
    1. Wiesenfeld H. C., Hillier S. L., Krohn M. A., Landers D. V., Sweet R. L. (2003). Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin. Infect. Dis. 36, 663–668. 10.1086/367658
    1. Wilkinson D., Ramjee G., Tholandi M., Rutherford G. (2002). Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men. Cochrane Database Syst. Rev. 2002:CD003936 10.1002/14651858.CD003936
    1. Workowski K. A., Bolan G. A. (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64, 1–137.
    1. Yarbrough V. L., Winkle S., Herbst-Kralovetz M. M. (2015). Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum. Reprod. Update 21, 353–377. 10.1093/humupd/dmu065
    1. Zárate G., Santos V., Nader-Macias M. E. (2009). Protective effect of vaginal Lactobacillus paracasei CRL 1289 against urogenital infection produced by Staphylococcus aureus in a mouse animal model. Infect. Dis. Obstet. Gynecol. 2009:48358. 10.1155/2007/48358
    1. Zevin A. S., Xie I. Y., Birse K., Arnold K., Romas L., Westmacott G., et al. . (2016). Microbiome composition and function drives wound-healing impairment in the female genital tract. PLoS Pathog. 12:e1005889. 10.1371/journal.ppat.1005889

Source: PubMed

3
Abonner